Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
179.25
-3.3 (-1.81%)
BSENSE

Nov 20

BSE+NSE Vol: 1.68 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 965190,
    "name": "Wanbury",
    "stock_name": "Wanbury",
    "full_name": "Wanbury Ltd",
    "name_url": "stocks-analysis/wanbury",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "179.25",
    "chg": -3.3,
    "chgp": "-1.81%",
    "dir": -1,
    "prev_price": "182.55",
    "mcapval": "635.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524212,
    "symbol": "WANBURY",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE107F01022",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.68 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/wanbury-965190-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Wanbury Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/wanbury-ltd-is-rated-sell-by-marketsmojo-4257280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/WanburyLtd_mojoScore_4257280.png",
        "date": "2026-11-10 10:10:43",
        "description": "Wanbury Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 November 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Wanbury Gains 4.87% This Week: Mixed Financials and Volatile Trading Shape Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/wanbury-gains-487-this-week-mixed-financials-and-volatile-trading-shape-performance-4255342",
        "imagepath": "",
        "date": "2026-11-07 14:04:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Week opens at Rs.190.15 with modest gains</p>\n                    <p><strong>Nov 3:</strong> Continued upward momentum to Rs.192.65 (+1.31%)</p>\n                    <p><strong>Nov 4:</strong> Slight dip to Rs.192.55 amid cautious trading</p>\n                    <p><strong>Nov 5:</strong> Quarterly results released; stock plunges 3.19% to Rs.186.40</p>\n                    <p><strong>Nov 6:</strong> Strong recovery with 6.76% surge to Rs.199.00</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.189.75</div></div>\n                    <div class..."
      },
      {
        "title": "Wanbury Ltd Reports Flat Quarterly Performance Amid Mixed Financial Trends",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/wanbury-ltd-reports-flat-quarterly-performance-amid-mixed-financial-trends-4252369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/WanburyLtd_fintrenddot_4252369.png",
        "date": "2026-11-05 11:01:00",
        "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has posted a flat financial performance for the quarter ended September 2026, signalling a stabilisation after a period of decline. While net sales and operating profit metrics reached new highs, the company’s profitability took a hit with a notable contraction in net profit after tax, reflecting ongoing challenges in margin management."
      },
      {
        "title": "Wanbury Ltd Gains 6.30%: Valuation Upgrade Amid Mixed Financial Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/wanbury-ltd-gains-630-valuation-upgrade-amid-mixed-financial-signals-4245805",
        "imagepath": "",
        "date": "2026-10-31 14:03:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Sharp 6.44% decline on valuation shift news</p>\n                    <p><strong>27 Oct:</strong> Upgrade to Sell rating on improved valuation</p>\n                    <p><strong>29 Oct:</strong> Stock gains 3.02% amid mixed financial trends</p>\n                    <p><strong>30 Oct:</strong> Week closes with 5.10% daily gain, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.178.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.189.75</div><div cl..."
      },
      {
        "title": "Wanbury Ltd Upgraded to Sell on Improved Valuation Amid Mixed Financial Trends",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/wanbury-ltd-upgraded-to-sell-on-improved-valuation-amid-mixed-financial-trends-4240325",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/WanburyLtd_mojoScore_4240325.png",
        "date": "2026-10-27 08:46:22",
        "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 26 Oct 2026. This change reflects a nuanced reassessment of the company’s valuation, quality, financial trends, and technical outlook amid ongoing operational headwinds and market underperformance."
      },
      {
        "title": "Wanbury Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/wanbury-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-market-challenges-4238230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/WanburyLtd_valuationdot_4238230.png",
        "date": "2026-10-26 08:01:38",
        "description": "Wanbury Ltd’s recent valuation adjustments have repositioned the pharmaceutical company as an attractive investment opportunity, despite ongoing sector headwinds and a challenging price performance relative to the broader market. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have notably improved, signalling a potential value play for discerning investors."
      },
      {
        "title": "Wanbury Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/wanbury-ltd-is-rated-strong-sell-4227630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/WanburyLtd_mojoScore_4227630.png",
        "date": "2026-10-16 10:11:10",
        "description": "Wanbury Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 October 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Wanbury Ltd Valuation Shifts Amidst Sector Volatility: A Detailed Analysis",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/wanbury-ltd-valuation-shifts-amidst-sector-volatility-a-detailed-analysis-4223359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/WanburyLtd_valuationdot_4223359.png",
        "date": "2026-10-13 08:00:47",
        "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from very attractive to fair, reflecting a nuanced change in market perception. Despite a recent downgrade to a Strong Sell rating, the company’s valuation metrics remain compelling relative to its peers, though caution is warranted given recent price declines and sector dynamics."
      },
      {
        "title": "Wanbury Ltd Gains 3.46%: 2 Key Technical Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/wanbury-ltd-gains-346-2-key-technical-factors-driving-the-week-4221187",
        "imagepath": "",
        "date": "2026-10-10 14:02:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Oct:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>6 Oct:</strong> Wanbury faces intensified bearish momentum amid technical downshift</p>\n                    <p><strong>9 Oct:</strong> Week closes at Rs.195.85, up 3.46% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.189.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.195.85</div><div class=\"stat-change positive\">+3.46%</div></div>\n                    <div class..."
      }
    ],
    "total": 92,
    "sid": "965190",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/wanbury-965190"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "20-Nov-2026",
      "details": "Wanbury Limiteds Tanuka API Facility Successfully Completes South Korea MFDS cGMP Inspection with Zero Observations",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "18-Nov-2026",
      "details": "Disclosure under Regulation 30 of the SEBI LODR 2015 - Investors Presentation on Q2 and Half Year ended 30.09.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "16-Nov-2026",
      "details": "Wanbury Limiteds Tanuku Plant - US FDA Inspection - Updates",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wanbury Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Jul 10",
          "dt": "2010-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

20-Nov-2026 | Source : BSE

Wanbury Limiteds Tanuka API Facility Successfully Completes South Korea MFDS cGMP Inspection with Zero Observations

Announcement under Regulation 30 (LODR)-Investor Presentation

18-Nov-2026 | Source : BSE

Disclosure under Regulation 30 of the SEBI LODR 2015 - Investors Presentation on Q2 and Half Year ended 30.09.2026.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

16-Nov-2026 | Source : BSE

Wanbury Limiteds Tanuku Plant - US FDA Inspection - Updates

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Wanbury Ltd has declared 10% dividend, ex-date: 29 Jul 10

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available